Global Water Resources Ekes Higher on Recent Legislation
Global Water Resources, Inc. (NASDAQ: GWRS) shares began Wednesday in the green. The Phoenix-based company, a pure-play water resource management concern, today recognized the recent passage of Arizona’s Assured Water Supply “Ag-to-Urban” program as a transformative development for water sustainability, housing, and economic growth across the state.The program allows landowners who cease agricultural operations to convert their water rights to the municipal sector for use in new development. By supporting the conversion of irrigated agricultural land—historically consuming an average of 3.8 acre-feet of water per acre annually in Phoenix Active Management Area (AMA) and 3.0 acre-feet in the Pinal AMA—into residential uses that require only a fraction of that volume, the program directly alleviates pressure on aquifers while enabling new development opportunities.The initiative is expected to significantly benefit the company’s Global Water – Santa Cruz Water Company, Inc. (GW-Santa Cruz) and Global Water – Palo Verde Utilities Company, Inc. (GW-Palo Verde) utilities that provide water, wastewater and recycled water services in Pinal County, Arizona. These two utilities are the company’s largest, collectively representing more than 56,000 active service connections in and around the City of Maricopa which represents approximately 87% of the company’s total active service connections.GWRS shares captured 18 cents, or 1.8%, to $10.26.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


